StoneX Group’s DNA X Inc SONM Stock Holding History

StoneX Group’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,056	Closed	-$23.2K	–	1009
2025 Q2	$23.2K	Buy	+1,056	New	+$26K	﹤0.01%	825
2022 Q3	–	Sell	-64	Closed	-$6.34K	–	491
2022 Q2	$6.34K	Buy	+64	New	+$7.23K	﹤0.01%	475

Other funds holding SONM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DWM

Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

StoneX Group's SONM Position: Q3 2025 in Review

StoneX Group sold out of DNA X Inc (SONM) in Q3 2025, closing a stake of 1,056 shares — an estimated $23.2K sold.

StoneX Group first reported a position in SONM in Q2 2022 and held it in 2 quarters. The position peaked at $23.2K in Q2 2025. 12 funds tracked by Wall St. Rank hold SONM as of Q3 2025.

StoneX Group reported no remaining DNA X Inc position as of Q3 2025 after selling out during the quarter.
StoneX Group sold 1,056 DNA X Inc shares in Q3 2025, an estimated $23.2K.
StoneX Group first reported a position in DNA X Inc in Q2 2022 and held it in 2 quarters.
StoneX Group's DNA X Inc position peaked at $23.2K in Q2 2025.
12 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2025.

Based on StoneX Group's 13F filing for Q3 2025, filed 14 Nov 2025.